• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Fujisawa Yutaka  藤澤 豊

ORCIDConnect your ORCID iD *help
… Alternative Names

藤澤 豊  フジサワ ユタカ

FUJISAWA YUTAKA  藤澤 豊

Less
Researcher Number 30511993
Other IDs
Affiliation (Current) 2025: 鈴鹿医療科学大学, 薬学部, 助手
Affiliation (based on the past Project Information) *help 2023: 鈴鹿医療科学大学, 薬学部, 助手
2015 – 2021: 鈴鹿医療科学大学, 薬学部, 助手
Review Section/Research Field
Principal Investigator
Radiation science / Basic Section 52040:Radiological sciences-related
Except Principal Investigator
Basic Section 52040:Radiological sciences-related / Radiation science
Keywords
Principal Investigator
神経内分泌腫瘍 / 悪性腫瘍診断/治療薬開発 / LAT1 / ATSM含有新規アミノ酸 / 次世代診断/治療薬 / Cu-64 / 新規非天然アミノ酸ATSMaa / Cu-64標識NET診断/治療薬開発 / 新規アミノ酸ATSMaa / ATSMaa … More / 次世代診断/治療薬開発 / 診断/治療用薬剤開発 / 診断/治療薬開発 / ATSM誘導体 / 64Cuキレーター / ソマトスタチン誘導体 … More
Except Principal Investigator
個別化医療 / 被ばく線量 / マウス / 67Cu / 90Y / 投与設計 / 実効線量 / 核医学治療 / PET / Cu-64 / 放射性薬剤 / ヘマトポルフィリン / がん診断 / PET診断 Less
  • Research Projects

    (5 results)
  • Research Products

    (11 results)
  • Co-Researchers

    (2 People)
  •  Optimizing the radiopharmaceutical administration design increases the therapeutic effect of nuclear medicine therapy

    • Principal Investigator
      飯田 靖彦
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Suzuka University of Medical Science
  •  Development of Cu-64/67 labeled novel amino acid as a radiotheranostics agent targeting LAT1 overexpressed in malignant tumorPrincipal Investigator

    • Principal Investigator
      Fujisawa Yutaka
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52040:Radiological sciences-related
    • Research Institution
      Suzuka University of Medical Science
  •  Development of radiotheranostic agents targeting neuroendocrine tumor: Cu-64-labeled somatostatin derivatives containing a novel amino acid ATSMaaPrincipal Investigator

    • Principal Investigator
      Fujisawa Yutaka
    • Project Period (FY)
      2017 – 2018
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Radiation science
    • Research Institution
      Suzuka University of Medical Science
  •  Development of NET theranosptic agents based on novel 64Cu-labeled somatostatin derivativesPrincipal Investigator

    • Principal Investigator
      Fujisawa Yutaka
    • Project Period (FY)
      2015 – 2016
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Radiation science
    • Research Institution
      Suzuka University of Medical Science
  •  Development of novel PET tracers with long half-lives using for tumor diagnosis

    • Principal Investigator
      IIDA YASUHIKO
    • Project Period (FY)
      2012 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Radiation science
    • Research Institution
      Suzuka University of Medical Science

All 2023 2022 2020 2018 2017 2016 2015 2014 2013 Other

All Journal Article Presentation

  • [Journal Article] Efficacy of nuclear medicine therapy with 67CuCl2 in mice bearing LS180 colon cancer.2023

    • Author(s)
      Y. Fujisawa, Y. Sugiura, H. Haba, A. Nambu, Y. Shigekawa, X. Yin, Y. Magata, Y. Iida
    • Journal Title

      RIKEN Accelerator Progress Report

      Volume: 56 Pages: 156-156

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-23K07193
  • [Journal Article] Differentiation of malignant tumours from granulomas by using dynamic [(18)F]-fluoro-L-α-methyltyrosine positron emission tomography.2015

    • Author(s)
      Yamaguchi A, Hanaoka H, Fujisawa Y, Zhao S, Suzue K, Morita A, Tominaga H, Higuchi T, Hisaeda H, Tsushima Y, Kuge Y, Iida Y.
    • Journal Title

      EJNMMI Res.

      Volume: 5 Issue: 1 Pages: 29-29

    • DOI

      10.1186/s13550-015-0109-z

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-15K08520, KAKENHI-PROJECT-15K09945, KAKENHI-PROJECT-24591824
  • [Presentation] 新規アミノ酸ATSMaaのLAT1標的薬剤としての可能性2022

    • Author(s)
      藤澤 豊
    • Organizer
      日本薬学会
    • Data Source
      KAKENHI-PROJECT-19K08133
  • [Presentation] 新規アミノ酸ATSMaaのアミノ酸トランスポーター標的化薬剤としての有用性評価2020

    • Author(s)
      藤澤豊、飯田靖彦
    • Organizer
      日本薬学会第140年会
    • Data Source
      KAKENHI-PROJECT-19K08133
  • [Presentation] 神経内分泌腫瘍診断/治療薬開発における新規非天然アミノ酸ATSMaaを用いたsomatostatin誘導体の物性最適化2018

    • Author(s)
      藤澤豊
    • Organizer
      日本薬学会 第138年会
    • Data Source
      KAKENHI-PROJECT-17K16491
  • [Presentation] ATSM-SST誘導体の次世代NET診断薬としての有用性評価2017

    • Author(s)
      藤澤 豊
    • Organizer
      日本薬学会第137年会
    • Place of Presentation
      仙台国際センター
    • Data Source
      KAKENHI-PROJECT-15K19824
  • [Presentation] 次世代NET診断/治療用薬剤の開発を目的としたATSM-SST誘導体の物性評価2016

    • Author(s)
      藤澤 豊
    • Organizer
      日本薬学会第136年会
    • Place of Presentation
      ハシフィコ横浜
    • Year and Date
      2016-03-28
    • Data Source
      KAKENHI-PROJECT-15K19824
  • [Presentation] ヒト乳腺がん細胞移入マウスにおける64Cu標識Hematoporphyrin誘導体の腫瘍集積性評価2014

    • Author(s)
      藤澤豊、峰田麻衣子、中須賀彩、山口藍子、富永英之、樋口徹也、対馬義人、橋本和幸、永井泰樹、飯田靖彦
    • Organizer
      薬学会第134年会
    • Place of Presentation
      熊本県熊本市
    • Data Source
      KAKENHI-PROJECT-24591824
  • [Presentation] DA-MB-231移入マウスにおける64Cu標識ヘマトポルフィリンの腫瘍集積性評価2013

    • Author(s)
      中須賀彩、藤澤豊、峰田麻衣子、山口藍子、富永英之、樋口徹也、対馬義人、橋本和幸、永井泰樹、飯田靖彦
    • Organizer
      第59回日本薬学会東海支部大会
    • Place of Presentation
      愛知県名古屋市
    • Data Source
      KAKENHI-PROJECT-24591824
  • [Presentation] MDA-MB-231移入マウスにおける64Cu標識ヘマトポルフィリンの腫瘍集積性評価2013

    • Author(s)
      中須賀彩、藤澤豊、峰田麻衣子、山口藍子、富永英之、樋口徹也、対馬義人、橋本和幸、永井泰樹、飯田靖彦
    • Organizer
      第59回日本薬学会東海支部 総会・大会
    • Place of Presentation
      名古屋
    • Data Source
      KAKENHI-PROJECT-24591824
  • [Presentation] Tumor imaging with 64Cu labeled Hematoporphyrin derivatives in MDA-MB-231 bearing mice.

    • Author(s)
      Fujisawa Y., Yamaguchi A., Mineta M., Nakasuka A., Tominaga H., Higuchi T., Tsushima Y., Hashimoto K., Nagai Y., Iida Y.
    • Organizer
      EANM'14 - Annual Congress of the European Association of Nuclear Medicine.
    • Place of Presentation
      Gothenburg, Sweden
    • Year and Date
      2014-10-18 – 2014-10-22
    • Data Source
      KAKENHI-PROJECT-24591824
  • 1.  IIDA YASUHIKO (60252425)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 5 results
  • 2.  鈴江 一友
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi